We also explored the potential therapeutic roles of METTL3/m6A by knocking down METTL3, and both the central and peripheral sympathetic activity were reduced apparently indicating that METTL3/m6A are the key components in microglia‐mediated inflammation in the PVN of MI. This evidence concerns the gene METTL3 and myocardial infarction.